Cardiology mafia egregiously obfuscates mortality differences between stents and CABG in EXCEL trial

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In
New User Registration
*Required field
This entry was posted in - Medical Devices, - NEJM, - Opinion, Cardiac surgery, Cardiology, FDA. Bookmark the permalink.